Document is current

Any future updates will be listed below

Co-administration of subtherapeutic doses of yohimbine and NaHS potentially ameliorates CKD-induced necroptosis by modulating RAAS/ROS imbalance, sympathetic overactivity, and inflammation

Crossref DOI link: https://doi.org/10.1007/s00210-025-04804-6

Published Online: 2025-11-22

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark